FDA

purple lightning tornado
Biotech

Electra shines with $183M fundraise for rare disease trial

The $183 million series C fundraise “reflects some encouraging signs in the market,” Electra CEO Kathy Dong told Fierce Biotech.
Gabrielle Masson Oct 22, 2025 8:26am
VanNaarden

Lilly oncology head weighs in on FDA cancer drug policies

Oct 21, 2025 11:53am
gold arrow pointing upward forward

Replimune's stock spikes 100% on FDA acceptance of resubmission

Oct 20, 2025 5:33pm
Silhouette of Businessman Entering Lit Door Passage in Darkness

Astellas turns down option to license Taysha gene therapy—again

Oct 17, 2025 10:50am
Blue background with pill pattern with the words The Top Line

Unpacking the FDA transparency push on CRLs

Oct 17, 2025 9:41am
cancelled flights

Kezar plans layoffs after FDA axes meeting to discuss next trial

Oct 17, 2025 8:55am